Cargando…
A systematic review of nonsynonymous single nucleotide polymorphisms in the renin–angiotensin–aldosterone system
In this recent publication review the authors aimed to collect evidence of impact of nonsynonymous single nucleotide polymorphisms (nsSNP) in the renin–angiotensin–aldosterone system on patients’ phenotype not only regarding arterial hypertension and its complications, but also the impact on other d...
Autores principales: | Rechciński, Tomasz, Kasprzak, Jarosław D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788732/ https://www.ncbi.nlm.nih.gov/pubmed/34060646 http://dx.doi.org/10.5603/CJ.a2021.0055 |
Ejemplares similares
-
Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review
por: Hassib, Mohab, et al.
Publicado: (2021) -
An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers
por: Maideen, Naina Mohamed Pakkir, et al.
Publicado: (2022) -
Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19)
por: Banwait, Ranjit, et al.
Publicado: (2021) -
Effects of Renin-Angiotensin-Aldosterone System Inhibition on Left Ventricular Hypertrophy, Diastolic Function, and Functional Status in Patients With Hypertrophic Cardiomyopathy: A Systematic Review
por: Akhtar, Hamza, et al.
Publicado: (2022) -
Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
por: Gambaryan, Stepan, et al.
Publicado: (2023)